OVID · NASDAQ · Biotechnology

Ovid Therapeutics (OVID)

Develops targeted small molecules for neurological disorders involving neuronal hyperexcitability.

$2.57
After hours−0.01 (−0.19%)
At close$2.58(−6.70%)